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Introduction
Mammalian cell culture medium development has widely
evolved in recent years. The use of hydrolysates as serum
replacement has led to process variability due to lot-to-
lot variations. The undefined composition of these media
could also increase the process optimization timelines,
sometimes with limited impact on process performances.
With the reduction of process development activities for
preclinical and Phase I studies, medium and feed plat-
forms raised. The objective of the media was to ensure
cell growth only in order to go as fast as possible to pro-
duction bioreactors while the feeds were responsible for
productivity and production length. Either companies
spent several months if not years to develop their own
generic medium and feed platforms or they used com-
mercial ones, sometimes under licenses. The medium
and feed platform assessment also started earlier in the
product development process. Clone screening was per-
formed more and more in fed-batch conditions rather
than batch ones. Thus screening tools, scale-down mod-
els of bioreactors, with lower and lower working volumes
were designed. Another cell culture process evolution
was the development of new expression systems without
any selection agents. In order to assess our screening
scale-down model, between 20 to 35 chemically defined
platforms from 9 suppliers were screened with 3 CHO
host cell lines/expression systems.
Methods
The following protocol was followed for 3 different
CHO cell lines producing mAb:
- CHO host cell 1 - expression system n°1 : mAb I
- CHO host cell 1 - expression system n°2 : mAb II
- CHO host cell 2 - expression system n°3 : mAb III
Each medium was prepared, supplemented according to
cell requirements, 0.2 μm PVDF filtrated and stored into
at least 2 separated bottles. A sterility test was performed
on each bottle before use. Each cell line was thawed and
amplified during at least one week in its usual medium.
Then the cells were adapted to each medium for at least
8 passages in either 125 mL shake flasks or 50 mL spin
tubes in duplicate. Each media was preheated at 37°C
before use and one bottle was used per duplicate in order
to reduce contamination risk. After cell adaptation, fed-
batch platform assessment was performed in 50 mL spin
tubes at 37°C with a seeding density around 0.25 * 106
viable cells/mL. Every 2 to 3 days, samples were taken to
measure pH, pO2, pCO2, viable cell density, viability, glu-
cose and lactate levels. The feeding strategy applied was
the same for each cell line and agreed with each supplier.
The cultures were stopped when the viability was below
60% or after 16-17 days.
Results
The objective of cell culture media is to sustain cell
growth in order to quickly seed the production bioreac-
tor. Here are the doubling times measured on the 3 cell
lines (Table 1).
Despite having the same host cell, cell growth was dif-
ferent between mAb I and mAb II. The expression sys-
tem could have a significant impact on cell growth
behavior. In order to separate the different platform
results, a color was assigned to each supplier and plat-
form assessed (Figure 1).
Depending on the CHO host cell and the expression
system, each platform had different performances. Some
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Table 1 Doubling time of each cell line in each medium after adaptation.
mAb I mAb II mAb III
Cellvento™ CHO-200 medium 20 h 32 h 17 h
Supplier A medium 1 23 h 35 h 23 h
Supplier A medium 2 20 h 63 h 22 h
Supplier A medium 3 20 h 24 h 18 h
Supplier B medium 1 21 h 20 h 18 h
Supplier B medium 2 24 h 66 h 24 h
Supplier C medium 1 26 h 18 h 20 h
Supplier C medium 2 22 h 18 h 18 h
Supplier D medium 1 21 h 19 h 18 h
Supplier E medium 1 26 h 35 h 28 h
Supplier E medium 2 23 h 20 h 19 h
Supplier F medium 1 21 h 26 h 17 h
Supplier G medium 1 21 h 20 h 18 h
Supplier G medium 2 19 h
Supplier G medium 3 21 h
Supplier G medium 4 19 h
Supplier H medium 1 21 h
Supplier H medium 2 21 h
Figure 1 Colors assigned to each supplier. Final mAb I (top right side), mAb II (bottom left side) and mab III (bottom right side) titers for all
platforms compared to Cellvento ™ CHO-200 medium.
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platforms seemed to be more robust than others in
terms of final titer. The lactate metabolism was also
compared between the different platforms. Most of the
platforms had a maximum lactate concentration mea-
sured around 1 - 1.5 g/L. Some platforms went above
2 g/L of lactate, which could be difficult to scale-up in
bioreactors. The practical aspect was also studied as it
can facilitate the implementation and the tech transfer.
Some platforms assessed had 2 feeds added everyday
while others only had 1 feed added 3 times. Molecule
quality was also compared between platforms in terms
of High Molecule Weight and cIEF.
Conclusions
We have implemented a strong protocol for medium and
feed screening with up to 70 spin tubes manipulated in
parallel. More than 3000 sterile manipulations were per-
formed under a laminar flow without any contaminations.
These experiments allow us to define robust platforms in
terms of cell growth, productivity and metabolism on dif-
ferent CHO host cell lines and expression systems.
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